Myosin Kinase Inhibiting Peptide

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) 是 MLCK 的底物特异性多肽抑制剂。Myosin light chain kinase fragment 11-19 amide 可抑制低渗诱导的 Ca2+ 进入细胞。Myosin light chain kinase fragment 11-19 amide 可用于人类宫颈癌的研究。

Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) is a substrate-specific peptide inhibitor of MLCK. Myosin light chain kinase fragment 11-19 amide inhibits hypotonicity-induced Ca2+ entry. Myosin light chain kinase fragment 11-19 amide can be used in the research of human cervical cancer.

———

Myosin light chain kinase fragment 11-19 amide (5 μM) reduces the amplitude and rate of activation of noradrenaline-evoked non-selective cation current (Icat) in rabbit portal vein myocytes.Myosin light chain kinase fragment 11-19 amide inhibits swelling-activated taurine transport with an IC50 value of 2.0 μM.Myosin light chain kinase fragment 11-19 amide (10 μM) inhibits β2-integrin-mediated adhesion in neutrophils treated with KT5720 (25 μM).

———

Others

Other Targets

MLCK

———

———

119386-39-9

987.2

C40H78N18O11

>98% (HPLC)

———

———

———

(-20℃)

With Ice Pack

≥ 2 years